Seno Medical Instruments, Inc. With a strong management team and a renowned Medical Advisory Board, Seno is focused on commercializing and launching its innovative products. The company's first clinical application is for breast cancer diagnosis, providing functional imaging that detects the presence of angiogenesis, the growth of blood vessels around tumors.

Unlike traditional screening techniques, Seno's opto-acoustic imaging uses lasers and acoustics to detect breast cancer at its earliest stage without discomfort or exposure to harmful X-rays. In addition to breast cancer, Seno is actively pursuing applications for other types of cancer, including melanoma, thyroid, prostate, and colon cancer. The goal is to revolutionize cancer detection by providing more precise, earlier detection of tumors and distinguishing between benign and malignant growth without the need for biopsy.

Discover the future of cancer diagnosis with Seno Medical